Counseling Patients About Germline BRCA Mutations

Risk of Malignancy in Persons With a Germline BRCA1 or BRCA2 Pathogenic Variant

Rationale for Genetic Testing for BRCA Mutation

Approaches to Molecular Testing

Genetic Testing Guidelines for Ovarian Cancer

BRCA1/2 Testing Criteria

BRCA1/2 Testing Criteria (cont)

Patient Education About Genetic Testing

Possible Test Results

Patient Education After Genetic Testing

Implications for Family Members

Management Considerations

Management Considerations (cont)

Management Considerations: PARP Inhibitor Therapy for Ovarian Cancer

Follow-Up Discussions

Summary

Resources for Clinicians and Patients

Abbreviations